Skip to Content

T21 (Risedronate Sodium Delayed-Release 35 mg)

Pill with imprint T21 is White, Elliptical / Oval and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T21

Risedronate sodium delayed-release 35 mg T21
Risedronate sodium delayed-release 35 mg T21
Risedronate sodium delayed-release 35 mg T21
Risedronate sodium delayed-release 35 mg T21

Risedronate Sodium Delayed-Release

Imprint
T21
Strength
35 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
National Drug Code (NDC)
00093-5509

Get help with Imprint Code FAQs.

Related Images for "T21"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.